Literature DB >> 3174313

Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.

A T Shennan1, M S Dunn, A Ohlsson, K Lennox, E M Hoskins.   

Abstract

The follow-up records of 605 infants with birth weights of less than 1,500 g, with data available for 2 years after birth, were examined for evidence of abnormal pulmonary signs or symptoms. A total of 119 infants were identified and the neonatal oxygen requirements of these infants were compared with those of 486 infants who had normal pulmonary function. A requirement for oxygen at 28 days of life had a positive predictive value for abnormal pulmonary findings at the time of follow-up of only 38%, whereas 31% of those with normal pulmonary findings at the time of follow-up were still receiving oxygen at this age. The need for oxygen at 28 days was a good predictor of abnormal findings in infants of greater than or equal to 30 weeks' gestational age at birth but became increasingly less useful as gestational age decreased. It was found that, irrespective of gestational age at birth, the requirement for additional oxygen at 36 weeks' corrected postnatal gestational age was a better predictor of abnormal outcome, increasing the positive predictive value to 63%. The prediction of a normal outcome remained 90% for infants not receiving oxygen at this corrected gestational age.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3174313

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  228 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997.

Authors:  B N Manktelow; E S Draper; S Annamalai; D Field
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

Review 4.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 5.  Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.

Authors:  G K Suresh; J M Davis; R F Soll
Journal:  Cochrane Database Syst Rev       Date:  2001

6.  Postnatal weight increase and growth velocity of very low birthweight infants.

Authors:  E Bertino; A Coscia; M Mombrò; L Boni; G Rossetti; C Fabris; E Spada; S Milani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-04-25       Impact factor: 5.747

7.  Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Report of a Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

8.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Authors:  Rosemary D Higgins; Alan H Jobe; Marion Koso-Thomas; Eduardo Bancalari; Rose M Viscardi; Tina V Hartert; Rita M Ryan; Suhas G Kallapur; Robin H Steinhorn; Girija G Konduri; Stephanie D Davis; Bernard Thebaud; Ronald I Clyman; Joseph M Collaco; Camilia R Martin; Jason C Woods; Neil N Finer; Tonse N K Raju
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

9.  Prediction of respiratory outcome in extremely low gestational age infants.

Authors:  Richard B Parad; Jonathan M Davis; Jessica Lo; Mark Thomas; Neil Marlow; Sandy Calvert; Janet L Peacock; Anne Greenough
Journal:  Neonatology       Date:  2015-03-03       Impact factor: 4.035

Review 10.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.